IPQ Inside the global regulatory dialogue

FDA Releases Guideline on Animal Drug Substance CMC Filings in CTD Format

Aug 20th, 2010

Please Log in to print the full article

FDA’s Center for Veterinary Medicine (CVM) has released a guideline on how to file drug substance CMC information for new and abbreviated new animal drug applications (NADAs/ANADAs) in the Common Technical Document (CTD) format.  The CMC guideline was released as a final version rather than as a draft for comment.

The NADA/ANADA drug substance CMC guideline fills in a gap that was left with the 2006 withdrawal of a 1987 umbrella guideline on the Format and Content of a Chemistry, Manufacturing, and Controls Section of an Application that encompassed both human and animal drug filings.  The umbrella guideline was withdrawn along with a handful of others that FDA deemed  “inconsistent with the agency’s initiative, Pharmaceutical Current Good Manufacturing Practices (CGMPs) for the 21st Century.”

[More on the background and content of the CVM guideline along with relevant links is provided for subscribers on page 2.]

Pages: 1 2

    ©2021 IPQ Publications